Posttransplant cyclophosphamide after allogeneic hematopoietic cell transplantation mitigates the immune activation induced by previous nivolumab therapy
Juan C. Nieto, Elisa Roldán, Isabel Jiménez, María Laura Fox, Júlia Carabia, Guillermo Ortí, Lluís Puigdefàbregas, Laura Gallur, Gloria Iacoboni, Priyanka Raheja, Ana Pérez, Sabela Bobillo, Olga Salamero, Carlos Palacio, David Valcárcel, Marta Crespo, Francesc Bosch, Pere Barba
Topics & Concepts
NivolumabMedicineSirolimusTransplantationCyclophosphamideTacrolimusHematopoietic stem cell transplantationT cellImmunologyImmune systemInternal medicineImmunotherapyOncologyChemotherapyHematopoietic Stem Cell TransplantationImmune Cell Function and InteractionImmunotherapy and Immune Responses